A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule Inhibitor of BET Proteins, in Patients with Relapsed or Refractory Lymphoma
暂无分享,去创建一个
I. Flinn | P. Trojer | M. Maris | A. Senderowicz | A. Younes | K. Blum | J. Supko | A. Goy | J. Abramson | G. Colak | R. Rippley | S. Efuni | Suresh Bobba